109162 ⎘
Structure or type of the nucleic acid; Chemical structure of the backbone Phosphorothioates
COMPOSITIONS AND THEIR USES DIRECTED TO HEPCIDIN
#3302ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION
#3303Oligomeric compounds and compositions for the use in modulation of target nucleic acids
#3304Anti-MicroRNA oligonucleotide molecules
#3305Modifications for Antisense Compounds
#3306DOUBLE-STRANDED OLIGONUCLEOTIDES
#3307Compositions and methods for inhibiting expression of huntingtin gene
#3308Molecular Interactions in Hematopoietic Cells
#3309Anti-connexin compounds targeted to connexins and methods of use thereof
#3310Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
#3311METHODS OF MODULATING AN IMMUNE RESPONSE TO A VIRAL INFECTION
#3312MODULATION OF INFLAMMATORY RESPONSES BY FACTOR XI
#3313Antisense modulation of C-reactive protein expression
#3314Antisense modulation of PTP1B expression
#3315METHODS OF TREATING CANCERS WITH HER3 ANTISENSE OLIGONUCLEOTIDES
#3316Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
#3317Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means
#3318Lipids and compositions for the delivery of therapeutics
#3319Treatment of neurological disorders by dsRNA administration
#3320miR-33 INHIBITORS AND USES THEREOF
#3321Oligonucleotide analogs as therapeutic agents
#3322Treatment of ABCA1 gene related diseases by inhibition of a natural antisense transcript to ABCA1
#3323OLIGONUCLEOTIDE COMPRISING AN INOSINE FOR TREATING DMD
#3324TREATMENT OF TRISTETRAPROLINE (TTP) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TTP
#3325MicroRNAs In Idiopathic Pulmonary Fibrosis
#3326COMPOSITE POLYNUCLEIC ACID THERAPEUTICS
#3327Compositions and methods for the treatment of sepsis and other disorders involving phospholipase Ainduction
#3328Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#3329Reduced size self-delivering RNAi compounds
#3330Method for inhibiting the activity of mir-155
#3331Agonists of toll-like receptor 3 and methods of their use
#3332Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#3333Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#3334Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof
#3335Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#3336Short interfering ribonucleic acid (siRNA) for oral administration
#3337Short interfering ribonucleic acid (siRNA) for oral administration
#3338Antisense modulation of superoxide dismutase 1, soluble expression
#3339Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#3340Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#3341Compositions and methods for inhibiting expression of a gene from the JC virus
#3342Short interfering ribonucleic acid (siRNA) for oral administration
#3343Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA
#3344ANTISENSE MODULATION OF CHOLESTERYL ESTER TRANSFER PROTEIN EXPRESSION
#3345Compositions and methods for inhibiting expression of mutant EGFR gene
#3346Nucleic acids comprising formula (NGXGN)and derivatives thereof as immunostimulating agent/adjuvant
#3347Optimized Methods For Delivery Of DSRNA Targeting The PCSK9 Gene
#3348Compositions And Methods For Increasing Cellular Uptake Of RNAi Via SID-1
#3349Antisense compositions and methods of making and using same
#3350Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1
#3351ANIMAL MODEL FOR PARKINSON'S DISEASE
#3352COMPOUNDS FOR THE MODULATION OF BETA-CATENIN EXPRESSION
#3353Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2
#3354TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF
#3355Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF
#3356LNA ANTAGONISTS TARGETING THE ANDROGEN RECEPTOR
#3357SNPs of apolipoprotein B and modulation of their expression
#3358Human telomerase catalytic subunit
#3359IMMUNOMODULATORY AGENTS AND METHODS OF USE
#3360Compositions and methods for diminishing viral infection and inflammation associated with viral infection
#3361Oligomeric compounds and methods
#3362Modulation of exon recognition in pre-mRNA by interfering RNA structure
#3363Compositions and their uses directed to huntingtin
#3364BRANCHED CATIONIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEM
#3365RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#3366RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#3367TREATMENT OF TUMOR SUPPRESSOR GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO THE GENE
#3368MODULATION OF TRANSTHYRETIN EXPRESSION
#3369Means and methods for counteracting muscle disorders
#3370USE OF MIR-126 FOR ENHANCING HEMATOPOIETIC STEM CELL ENGRAFTMENT, FOR ISOLATING HEMATOPOIETIC STEM CELLS, AND FOR TREATING AND MONITORING THE TREATMENT OF ACUTE MYELOID LEUKEMIA
#3371Compounds and methods for the treatment of inflammatory diseases of the CNS
#3372RNA Interference Mediated Inhibition of Epithelial Sodium Channel (ENaC) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#3373Increased Expression of Specific Antigens
#3374Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
#3375Compositions and methods for inhibiting expression of the HAMP gene
#3376Spinal muscular atrophy treatment via targeting SMN2 catalytic core
#3377Gene Silencing by Single-Stranded Polynucleotides
#3378ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF
#3379RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#3380METHODS AND MEANS FOR EFFICIENT SKIPPING OF AT LEAST ONE OF THE FOLLOWING EXONS OF THE HUMAN DUCHENNE MUSCULAR DYSTROPHY GENE: 43, 46, 50-53
#3381Organic compositions to treat beta-ENaC-related diseases
#3382Reduced size self-delivering RNAi compounds
#3383Method of Treating Neurodegenerative Disease
#3384RNAi Modulation of the BCR-ABL Fusion Gene and Uses Thereof
#3385NOVEL siRNAS AND METHODS OF USE THEREOF
#3386Compositions and methods for inhibiting expression of CD274/PD-L1 gene
#3387METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASE
#3388Targeting MicroRNAs For The Treatment Of Liver Cancer
#3389Method for generating aptamers with improved off-rates
#3390Nuclease resistant double-stranded ribonucleic acid
#3391MODIFIED OLIGORIBONUCLEOTIDE ANALOGS WITH ENHANCED IMMUNOSTIMULATORY ACTIVITY
#3392Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGF
#3393RNA interference in skin indications
#3394Neutral nanotransporters
#3395SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
#3396dsRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTION
#3397Modulation of C-reactive protein expression
#3398Compositions and methods for inhibiting expression of the PCSK9 gene
#3399Oligomeric compounds for the modulation of HIF-1α expression
#3400Oligomeric compounds and compositions for use in modulation of small non-coding RNAS
#3401Use of inhibitors of leukotriene B4 receptor BLT2 for treating human cancers
#3402PHOSPHOROTHIOATE OLIGONUCLEOTIDES AND NON-NUCLEOSIDIC PHOSPHOROTHIOATES AS DELIVERY AGENTS FOR iRNA AGENTS
#3403ANTISENSE MODULATION OF STEAROYL-COA DESATURASE EXPRESSION
#3404ENHANCED ANTISENSE OLIGONUCLEOTIDES
#3405SMAD7 INHIBITOR COMPOSITIONS AND USES THEREOF
#3406Modulation of gene expression by oligomers targeted to chromosomal DNA
#3407Immunostimulatory oligoribonucleotides
#3408Therapeutic compositions
#3409Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides
#3410SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES
#3411Compositions and methods for inhibiting expression of a gene from the ebola virus
#3412High Affinity Nucleic Acid Ligands of Complement System Proteins
#3413Modulation of HIF1α and HIF2α expression
#3414Multiple CpG oligodeoxynucleotide and their use to induce an immune response
#3415Methods and means for treating DNA repeat instability associated genetic disorders
#3416RNAi modulation of SCAP and therapeutic uses thereof
#3417Potent LNA oligonucleotides for the inhibition of HIF-1A expression
#3418Use of inhibitory oligonucleotides to treat autoimmune disease
#3419Combination Therapies Against Cancer
#3420Modulation of HSP47 expression
#3421METHODS FOR MODULATING EXPRESSION OF CREB
#3422MODULATION OF TRANSFORMING GROWTH FACTOR-BETA 1 EXPRESSION
#3423Chemotherapy involving antisense oligonucleotides for preventing and/or treating pulmonary fibrosis
#3424Conjugates For Use In Hepatocyte Free Uptake Assays
#3425Complement antagonists and uses thereof
#3426RNA COMPOSITIONS FOR MODULATING IMMUNE RESPONSE
#3427Modulation of glucose-6-phosphatase translocase expression
#3428Anti-MicroRNA oligonucleotide molecules
#3429INFLUENZA CAP-LEADER SEQUENCE
#34305′ triphosphate oligonucleotide with blunt end and uses thereof
#3431COMPOSITIONS AND METHODS FOR ENHANCED SENSITIVITY AND SPECIFICITY OF NUCLEIC ACID SYNTHESIS
#3432Modulation of CD40 expression
#3433NUCLEIC-ACID PHARMACEUTICAL COMPOSITION FOR CANCER THERAPY
#3434Bispecific oligonucleotide for the treatment of CNS malignancies
#3435Modulation of SMRT expression
#3436Compositions and methods for inhibiting expression of XBP-1 gene
#3437COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF IL-18 GENES
#3438Methods for treating androgen receptor dependent disorders including cancers
#3439RNA antagonists targeting Hsp27
#3440Oligonucleotides for treating inflammation and neoplastic cell proliferation
#3441Diblock copolymers and polynucleotide complexes thereof for delivery into cells
#3442Treatment of fibrotic conditions
#3443Compositions and their uses directed to acetyl-CoA carboxylases
#3444SYNTHETIC AGONISTS OF TLR9
#3445POLYPEPTIDE COMPOUNDS FOR INHIBITING ANGIOGENESIS AND TUMOR GROWTH
#3446Antiviral Oligonucleotides Having a Conserved G4 Core Sequence
#3447COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE
#3448RNA ANTAGONISTS TARGETING GLI2
#3449Diagnosis and Treatment of Malignant Neoplasms
#3450Materials and Methods for Treatment of Cancer
#3451Methods for modulating expression of RBP4
#3452Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
#3453Compositions and Methods for Inhibiting Expression of TGF-BETA Receptor Genes
#3454DELIVERY OF RNAI CONSTRUCTS TO OLIGODENDROCYTES
#3455CHEMICALLY MODIFIED OLIGONUCLEOTIDES AND USES THEREOF
#3456Antisense antiviral compound and method for treating influenza viral infection
#3457Antisense modulation of C-reactive protein expression
#3458Compositions and methods for inhibiting expression of IKK-B gene
#3459COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF KIF10 GENES
#3460Compositions and their uses directed to PTPRU
#3461Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity
#3462SOLUBLE TNF RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
#3463Compositions and methods for inhibiting expression of anti-apoptotic genes
#3464Compositions and their uses directed to gemin genes
#3465Treatment of neuropathic pain using anti-thrombospondin antibodies
#3466Antisense formulation
#3467ANTISENSE MODULATION OF BCL2-ASSOCIATED X PROTEIN EXPRESSION
#3468Modification of MYD88 splicing using modified oligonucleotides
#3469METHOD OF TREATING NEURODEGENERATIVE DISEASE
#3470Compounds for the modulation of beta-catenin expression
#3471OLIGONUCLEOTIDES AFFECTING EXPRESSION OF PHOSPHODIESTERASES
#3472IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
#3473RNA antagonist compounds for the modulation of PIK3CA expression
#3474MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes
#3475RNAi Modulation of the RHO-A Gene and Uses Thereof
#3476Immunomodulatory Compositions, Combinations and Methods
#3477METHODS FOR MODULATING IMMUNE RESPONSES TO AAV GENE THERAPY VECTORS
#3478RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)
#3479Compounds and methods for modulating expression of SGLT2
#3480TREATMENT OF RHEUMATOID ARTHRITIS
#3481Compositions and methods for inhibiting expression of a gene from the ebola virus
#3482Modulation of apolipoprotein C-III expression
#3483MODULATION OF FACTOR 9 EXPRESSION
#3484MODULATION OF OLIGONUCLEOTIDE CPG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES
#3485Therapeutic compositions
#3486Method for reducing scarring during wound healing using antisense compounds directed to CTGF
#3487Antisense oligonucleotide modulation of STAT3 expression
#3488DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION
#3489Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#3490Use of antisense oligonucleotides to effect translation modulation
#3491Modified RNAi polynucleotides and uses thereof
#3492Modulation of apolipoprotein (a) expression
#3493CCR2 INHIBITORS FOR TREATING CONDITIONS OF THE EYE
#3494Inhibitors of DNA Immunostimulatory Sequence Activity
#3495Compositions and methods for inhibiting expression of CD45 gene
#3496Modulation of T cell signaling threshold and T cell sensitivity to antigens
#3497Nucleic acid microspheres, production and delivery thereof
#3498Methods and Compositions for Treating Neurological Disease
#3499TRPM-2 antisense therapy
#3500Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#3501Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#3502Lipid formulated dsRNA targeting the PCSK9 gene
#3503RNA interference mediated inhibition of human immunodeficiency virus (HIV) gene expression using short interfering nucleic acid (siNA)
#3504COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 GENE
#3505RNAi probes targeting cancer-related proteins
#3506Methods and compositions for inhibition of immune responses and autoimmunity
#3507Antisense oligonucleotides targeted to the coding region of thymidylate synthase and uses thereof
#3508Peptide-conjugated oligonucleotide therapeutic and method of making and using same
#3509EFFECTS OF APOLIPOPROTEIN B INHIBITION ON GENE EXPRESSION PROFILES IN ANIMALS
#3510METHODS AND COMPOSITONS FOR ANTISENSE VEGF OLIGONUCLEOTIDES
#3511Pharmaceutical compositions for treatment of HCV patients that are poor-responders to interferon
#3512Modulation of SGLT2 expression
#3513Lipid formulation
#3514RNA Antagonist Compounds for the Modulation of MCL-1
#3515Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field
#3516MODULATION OF HIF1 BETA EXPRESSION
#3517IMMUNOSTIMULATORY OLIGORIBONUCLEOTIDES
#3518Antisense Oligonucleotides Against VR1
#3519Modulation of forkhead box O1A expression
#3520Nucleic acid modulators of glycoprotein VI
#3521ANTIANDROGEN OLIGONUCLEOTIDES USABLE FOR THE TREATMENT OF DERMATOLOGICAL ANDROGEN-RELATED DISORDERS RELATING TO ANDROGEN METABOLISM, THEIR PHARMACEUTICAL COMPOSITIONS, THEIR USES AND TREATMENT METHOD
#3522RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)
#3523Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules
#3524RNA INTERFERENCE MEDIATED INHIBITION OF ADENOSINE A1 RECEPTOR (ADORA1) GENE EXPRESSION USING SHORT INTERFERING RNA
#3525IMMUNOSTIMULATION BY CHEMICALLY MODIFIED RNA
#3526Antibodies directed to mGluR7
#3527Modulation of factor 7 expression
#3528MicromiRs
#3529Oligonucleotide Compositions with Enhanced Efficiency
#3530Compositions and methods for inhibiting expression of Huntingtin gene
#3531Administering antisense oligonucleotides complementary to human apolipoprotein B
#3532RNAi MODULATION OF HIF-1 AND THERAPUTIC USES THEREOF
#3533Compounds and methods for improving cellular uptake of oligomeric compounds
#3534Antisense modulation of fibroblast growth factor receptor 4 expression
#3535Anti-microRNA oligonucleotide molecules
#3536Composition of Asymmetric RNA Duplex As MicroRNA Mimetic or Inhibitor
#3537ANTISENSE OLIGONUCLEOTIDES FOR TREATING ATOPIC DISEASES AND NEOPLASTIC CELL PROLIFERATION
#3538Dosage of oligonucleotides suitable for the treatment of tumors
#3539METHODS FOR INCREASING IN VIVO EFFICACY OF OLIGONUCLEOTIDES AND INHIBITING INFLAMMATION IN MAMMALS
#3540Micro-RNA family that modulates fibrosis and uses thereof
#3541Combination treatment for the treatment of hepatitis C virus infection
#3542RECEPTOR TARGETED OLIGONUCLEOTIDES
#3543METHODS AND COMPOSITIONS FOR MODULATING TISSUE FACTOR
#3544Modulation of apolipoprotein (A) expression
#3545RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles
#3546Targeting microRNAs for the treatment of liver cancer
#3547Method for inhibiting the activity of mir-155
#3548METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASE
#3549Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activity
#3550Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
#3551Small interfering DNA (siDNA) oligonucleotides as an antiviral agent against Herpes virus infections
#3552Efficient Nuclear Delivery of Antisense Oligonucleotides or siRNA In Vitro and In Vivo by Nano-Transforming Polymersomes
#3553SHORT RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF HIF-1ALPHA
#3554Oligomeric compounds and compositions for use in modulation of pri-miRNAs
#3555DSRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTIONS
#3556Sense oligonucleotide capable of controlling the expression of iNOS and composition comprising the same
#3557Therapeutic compositions
#3558Antisense modulation of kinesin-like 1 expression
#3559RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
#3560LNA antagonists targeting the androgen receptor
#3561MODULATION OF GLUCAGON RECEPTOR EXPRESSION
#3562RNAi modulation of the BCR-ABL fusion gene and uses thereof
#3563RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#3564Compositions and methods for inhibiting expression of a gene from the JC virus
#3565Chemically modified oligonucleotides for use in modulation micro RNA and uses thereof
#3566MODULATION OF GLUCOCORTICOID RECEPTOR EXPRESSION
#3567RNAi inhibition of alpha-ENaC expression
#3568RNAi inhibition of alpha-ENaC expression
#3569Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
#3570RNAi modulation of APOB and uses thereof
#3571IMMUNOSTIMULATORY ACTIVITY OF PALINDROMIC IMMUNE MODULATORY OLIGONUCLEOTIDES (IMO) CONTAINING DIFFERENT LENGTHS OF PALINDROMIC SEGMENTS
#3572Synthetic RNA-based agonists of TLR7
#3573Short oligomer antagonist compounds for the modulation of target mRNA
#3574RNAi inhibition of alpha-ENaC expression
#3575RNAi inhibition of alpha-ENaC expression
#3576Nicked or gapped nucleic acid molecules and uses thereof
#3577Compositions and methods for inhibiting expression of the HAMP gene
#3578Method of Treating Neurodegenerative Disease
#3579Use of antisense oligonucleotides against CPLA2 in the treatment of cancer
#3580Modulation of Stat 6 Expression for the Treatment of Airway Hyperresponsiveness
#3581Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in the treatment of cancer
#3582ANTISENSE MODULATION OF ACYL COA CHOLESTEROL ACYLTRANSFERASE-2 EXPRESSION
#3583Antisense compounds
#3584MODIFIED POLYNUCLEOTIDES FOR USE IN RNA INTERFERENCE
#3585Tumour growth inhibitory compounds and methods of their use
#35865'-Substituted-2-F' Modified Nucleosides and Oligomeric Compounds Prepared Therefrom
#3587RNAi inhibition of alpha-ENaC expression
#3588Compositions of TLR ligands and antivirals
#3589Immunostimulatory sequence oligonucleotides and methods of using the same
#3590METHODS AND MEANS FOR TREATING DNA REPEAT INSTABILITY ASSOCIATED GENETIC DISORDERS
#3591RNAi modulation of SCAP and therapeutic uses thereof
#3592RNA interference mediated inhibition of protein tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)
#3593dsRNA For Treating Viral Infection
#3594dsRNA FOR TREATING VIRAL INFECTION
#3595METHODS OF REDUCING PAPILLOMAVIRUS INFECTION USING IMMUNOMODULATORY POLYNUCLEOTIDE SEQUENCES
#3596ANTIVIRAL OLIGONUCLEOTIDES TARGETING RSV
#3597Enhanced biotherapeutic production using inhibitory RNA
#3598ANTIVIRAL OLIGONUCLEOTIDES TARGETING VIRAL FAMILIES
#3599DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS
#3600RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA)